Astria Therapeutics, Inc. (ATXS)
Jan 26, 2026 - ATXS was delisted (reason: acquired by BCRX)
12.58
0.00 (0.00%)
Inactive · Last trade price on Jan 22, 2026

Astria Therapeutics Revenue

Astria Therapeutics had revenue of $706.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $706.00K.

Revenue (ttm)
$706.00K
Revenue Growth
n/a
P/S Ratio
1,017.18
Revenue / Employee
$9,051
Employees
78
Market Cap
718.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro